Navigation Links
Archi-Tech Closes the Gap Between Pharmaceutical Managed Care and Primary Sales with Pull-Through Reporting Capabilities
Date:9/1/2009

EWING, N.J., Sept. 1 /PRNewswire/ -- Archi-Tech Systems, a leader in pharmaceutical data analysis and reporting solutions, today announced the availability of managed care pull-through reporting across all of its products. Archi-Tech's managed care pull-through reports and analysis tools provide access to timely and up-to-date information about plan performance and formulary status -- which has become increasingly important as the availability of prescriber-level data declines. With fast, easy, and accurate access to current pull-through data, National Account Managers, primary sales teams, and managed care sales teams alike can be better informed about the impact of contract levels, costs, requirements, and more on key products -- ultimately improving strategic planning and sales force effectiveness.

"In the current environment, as changes in health plans continue to impact the pharmaceutical industry on a near-daily basis, it is more important than ever for managed care, sales operations, and field representatives to be on the same page," said Prashant Kohli, Vice President of Sales & Marketing for Archi-Tech. "The ability to immediately access pull-through reporting on a wide range of health plan data is essential for today's pharmaceutical companies. It allows them to build successful sales strategies that make the best use of both time and dollars, and maximize every opportunity in the highly competitive marketplace to increase volume and drive success."

Archi-Tech's data analysis and reporting tools enable the creation of ad-hoc pull-through reports on a wide range of data, at any level of detail -- whether for identifying the performance and success of pull-through for a product by geography, or comparing the performance of health plan contracts including the activity of each plan's top prescribers, and more. With the touch of a button, users can access information about formulary status, contract changes, costs, required authorizations, and more, for both their own company and for competitors. Data can be exported into Excel or PDF for quick viewing in meetings and on the road. Custom reports are also available to meet specific client business requirements, providing the key actionable information required to support managed care initiatives at all levels of an organization, from management to the sales force.

About Archi-Tech

Archi-Tech Systems is a leading provider of solutions for instant analytics and powerful reporting for pharmaceutical sales, marketing, and managed care departments. Balancing deep data expertise with advanced technology solutions and a unique service model, Archi-Tech addresses the full scope of a company's data analysis and reporting needs, no matter how simple or complex. The company's solutions offer unmatched speed and compression for any type of data, from any source, regardless of volume or complexity. In addition, the Archi-Tech team offers more than 100 years of combined experience with industry leading data vendors, and direct pharmaceutical client service experience. This translates to a unique understanding of the data, and exactly how our clients need to use it. For more information, visit www.archi-tech.com.


'/>"/>
SOURCE Archi-Tech Systems
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Kiss One-Size-Fits-None Goodbye: Archi-Tech Systems Offers First SFA Solution Targeted to Pharmaceutical Sales Organizations
2. Archi-Tech InView Now Supports Managed Care Data, Offering an Interactive Dashboard for On-Demand Sales Planning and Reporting
3. HEI, Inc. Closes on Sale of RFID Division Assets
4. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
5. Actor Joe Pantoliano Discloses Depression; Talks About His Latest Movie and His Sensitive Side
6. Stryker Discloses Informal Inquiry Made by United States Securities and Exchange Commission
7. MediKeeper Closes Series A Financing Round with PacifiCap as Lead Investor
8. Nexia Closes Acquisition of Green Endeavors; Landis Salons On Track to Generate Revenues of $2.2 Million in 2007
9. Pfizer Closes La Jolla Campus Due to Continuing Fire Emergency
10. NovaBay Pharmaceuticals Closes Initial Public Offering of Common Stock
11. BCP Veterinary Pharmacy Helps Cure Diabetic Cats with BCP PZI(R), the Closest Match to Feline Insulin Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 29, 2017 , ... Dr. Angela Cotey, a noted general dentist in Mt. ... patients, with or without a referral. Dr. Cotey knows that interceptive orthodontics ... experience. When patients receive early treatment, they may achieve straight teeth with less treatment ...
(Date:3/29/2017)... ... 2017 , ... An inventor from Raynham, Mass., knows the ... conjunction with my braces always rubbed against the inside of my cheeks, causing ... problem." The O.B.S. was the result of his brainstorming. , This patent-pending invention ...
(Date:3/29/2017)... , ... March 29, 2017 ... ... and South Hills of Pittsburgh now have easier access to the robotic-assisted ... by Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and Jefferson ...
(Date:3/28/2017)... ... March 28, 2017 , ... A recent Bellwether Education ... quality, the field must first improve teacher preparation program design. It then asserts ... and that decades of input- and outcome-based research has failed to improve teacher ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, ... be invited to the Siemens Healthineers annual customer education symposium, a world-class learning ... take place from March 27 - 31, 2017 at the Atlanta Marriott Marquis ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , March 28, 2017 The ... (dupilumab) injection to treat adults with moderate-to-severe eczema ... eczema is not controlled adequately by topical therapies, ... advisable. Dupixent can be used with or without ... demonstrates our commitment to approving new and innovative ...
(Date:3/28/2017)...  "US Cancer Generics Market Outlook 2022" report ... trend analysis related to the emergence and integration ... in US. The report analyzes various clinical and ... generics drugs in recent years. The introduction of ... dollars for various stake holders involved US cancer ...
(Date:3/28/2017)... , Va. and PHOENIX , March 28, ... Avella Specialty Pharmacy released a new white ... allergies and the use of latex in healthcare. Specifically, there ... in healthcare. In fact, the FDA has urged manufacturers to ... latex" claim from labels, because of the challenge to ensure ...
Breaking Medicine Technology: